These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 33749504)
1. Identification of differential DNA methylation alterations of ovarian cancer in peripheral whole blood based on within-sample relative methylation orderings. Li H; Jiang F; Du Y; Li N; Chen Z; Cai H; Guo Y; Hong G Epigenetics; 2022 Mar; 17(3):314-326. PubMed ID: 33749504 [TBL] [Abstract][Full Text] [Related]
2. Identifying CpG sites with different differential methylation frequencies in colorectal cancer tissues based on individualized differential methylation analysis. Yan H; He J; Guan Q; Cai H; Zhang L; Zheng W; Qi L; Zhang S; Liu H; Li H; Zhao W; Yang S; Guo Z Oncotarget; 2017 Jul; 8(29):47356-47364. PubMed ID: 28537885 [TBL] [Abstract][Full Text] [Related]
3. Individualized analysis reveals CpG sites with methylation aberrations in almost all lung adenocarcinoma tissues. Yan H; Guan Q; He J; Lin Y; Zhang J; Li H; Liu H; Gu Y; Guo Z; He F J Transl Med; 2017 Feb; 15(1):26. PubMed ID: 28178989 [TBL] [Abstract][Full Text] [Related]
4. Identification of the origin of brain metastases based on the relative methylation orderings of CpG sites. Liu H; Chen J; Chen H; Xia J; Wang O; Xie J; Li M; Guo Z; Chen G; Yan H Epigenetics; 2021 Aug; 16(8):908-916. PubMed ID: 32965167 [TBL] [Abstract][Full Text] [Related]
5. Detection of aberrant methylation of HOXA9 and HIC1 through multiplex MethyLight assay in serum DNA for the early detection of epithelial ovarian cancer. Singh A; Gupta S; Badarukhiya JA; Sachan M Int J Cancer; 2020 Sep; 147(6):1740-1752. PubMed ID: 32191343 [TBL] [Abstract][Full Text] [Related]
6. DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines. Houshdaran S; Hawley S; Palmer C; Campan M; Olsen MN; Ventura AP; Knudsen BS; Drescher CW; Urban ND; Brown PO; Laird PW PLoS One; 2010 Feb; 5(2):e9359. PubMed ID: 20179752 [TBL] [Abstract][Full Text] [Related]
8. Single CpG island methylation is not sufficient to maintain the silenced expression of CASPASE-8 apoptosis-related gene among women with epithelial ovarian cancer. Braga Lda C; Silva LM; Ramos AP; Piedade JB; Vidigal PV; Traiman P; da Silva Filho AL Biomed Pharmacother; 2014 Feb; 68(1):87-91. PubMed ID: 24412083 [TBL] [Abstract][Full Text] [Related]
9. Genome-wide de novo methylation in epithelial ovarian cancer. Michaelson-Cohen R; Keshet I; Straussman R; Hecht M; Cedar H; Beller U Int J Gynecol Cancer; 2011 Feb; 21(2):269-79. PubMed ID: 21270610 [TBL] [Abstract][Full Text] [Related]
10. Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis. Loginov VI; Pronina IV; Burdennyy AM; Filippova EA; Kazubskaya TP; Kushlinsky DN; Utkin DO; Khodyrev DS; Kushlinskii NE; Dmitriev AA; Braga EA Gene; 2018 Jul; 662():28-36. PubMed ID: 29631007 [TBL] [Abstract][Full Text] [Related]
11. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma. Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312 [TBL] [Abstract][Full Text] [Related]
12. Common DNA methylation alterations of Alzheimer's disease and aging in peripheral whole blood. Li H; Guo Z; Guo Y; Li M; Yan H; Cheng J; Wang C; Hong G Oncotarget; 2016 Apr; 7(15):19089-98. PubMed ID: 26943045 [TBL] [Abstract][Full Text] [Related]
13. DNA methylation and ovarian cancer. I. Analysis of CpG island hypermethylation in human ovarian cancer using differential methylation hybridization. Ahluwalia A; Yan P; Hurteau JA; Bigsby RM; Jung SH; Huang TH; Nephew KP Gynecol Oncol; 2001 Aug; 82(2):261-8. PubMed ID: 11531277 [TBL] [Abstract][Full Text] [Related]
14. A six-CpG-based methylation markers for the diagnosis of ovarian cancer in blood. Wang L; Ni S; Du Z; Li X J Cell Biochem; 2020 Feb; 121(2):1409-1419. PubMed ID: 31502352 [TBL] [Abstract][Full Text] [Related]
15. [Age-related DNA methylation changes in peripheral whole blood]. Li HD; Hong GN; Guo Z Yi Chuan; 2015 Feb; 37(2):165-173. PubMed ID: 25665643 [TBL] [Abstract][Full Text] [Related]
16. Hypermethylation of CpG islands is more prevalent than hypomethylation across the entire genome in breast carcinogenesis. Tan J; Gu Y; Zhang X; You S; Lu X; Chen S; Han X; Sun Y Clin Exp Med; 2013 Feb; 13(1):1-9. PubMed ID: 22212995 [TBL] [Abstract][Full Text] [Related]
17. CpG island methylation of DNA damage response genes in advanced ovarian cancer. Teodoridis JM; Hall J; Marsh S; Kannall HD; Smyth C; Curto J; Siddiqui N; Gabra H; McLeod HL; Strathdee G; Brown R Cancer Res; 2005 Oct; 65(19):8961-7. PubMed ID: 16204069 [TBL] [Abstract][Full Text] [Related]
18. Genome-scale screen for DNA methylation-based detection markers for ovarian cancer. Campan M; Moffitt M; Houshdaran S; Shen H; Widschwendter M; Daxenbichler G; Long T; Marth C; Laird-Offringa IA; Press MF; Dubeau L; Siegmund KD; Wu AH; Groshen S; Chandavarkar U; Roman LD; Berchuck A; Pearce CL; Laird PW PLoS One; 2011; 6(12):e28141. PubMed ID: 22163280 [TBL] [Abstract][Full Text] [Related]
19. Epigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation. Niskakoski A; Kaur S; Staff S; Renkonen-Sinisalo L; Lassus H; Järvinen HJ; Mecklin JP; Bützow R; Peltomäki P Epigenetics; 2014 Dec; 9(12):1577-87. PubMed ID: 25625843 [TBL] [Abstract][Full Text] [Related]
20. Methylation of leukocyte DNA and ovarian cancer: relationships with disease status and outcome. Fridley BL; Armasu SM; Cicek MS; Larson MC; Wang C; Winham SJ; Kalli KR; Koestler DC; Rider DN; Shridhar V; Olson JE; Cunningham JM; Goode EL BMC Med Genomics; 2014 Apr; 7():21. PubMed ID: 24774302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]